Metraipolis › archive › dc_d195b9bbbb4d

Aptamer-Based Heterobifunctional Targeted Degraders in Disease Treatment — Europe PMC PMID:42796602

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42796602
DOI
10.3390/molecules31183318
License (as archived)
solo-consultazione
Archived
2026-10-08T06:14:43.664Z
SHA-256 of the archived text
3637318da1bbcf0a8ecd72206a4498c5093268880c3cd9606830186252c00cb9
Stable URL of this page
https://metraipolis.com/documento/dc_d195b9bbbb4d

How to cite

Aptamer-Based Heterobifunctional Targeted Degraders in Disease Treatment — Europe PMC PMID:42796602 — Europe PMC (en), https://europepmc.org/article/MED/42796602 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d195b9bbbb4d (Metraipolis archive dc_d195b9bbbb4d, sha256 3637318da1bbcf0a8ecd72206a4498c5093268880c3cd9606830186252c00cb9)
BibTeX
@misc{dcd195b9bbbb4d,
  title = {Aptamer-Based Heterobifunctional Targeted Degraders in Disease Treatment — Europe PMC PMID:42796602},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42796602},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d195b9bbbb4d; sha256 3637318da1bbcf0a8ecd72206a4498c5093268880c3cd9606830186252c00cb9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42796602. Agents can read the archived copy with the MCP tool read_document.